BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 19635106)

  • 1. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications.
    Llombart B; Sanmartín O; López-Guerrero JA; Monteagudo C; Serra C; Requena C; Poveda A; Vistós JL; Almenar S; Llombart-Bosch A; Guillén C
    Histopathology; 2009 Jun; 54(7):860-72. PubMed ID: 19635106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
    Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
    Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of gene mutations in four cases of dermatofibrosarcoma protuberans.
    Saeki H; Tamada Y; Watanabe D; Akita Y; Matsumoto Y; Imai C; Kadono T; Maekawa T; Hattori N; Watanabe A; Torii H; Tamaki K
    Clin Exp Dermatol; 2006 May; 31(3):441-4. PubMed ID: 16681596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel fusion gene of collagen type I alpha 1 (exon 31) and platelet-derived growth factor B-chain (exon 2) in dermatofibrosarcoma protuberans.
    Nakanishi G; Lin SN; Asagoe K; Suzuki N; Matsuo A; Tanaka R; Makino E; Fujimoto W; Iwatsuki K
    Eur J Dermatol; 2007; 17(3):217-9. PubMed ID: 17478383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene mutation analysis in five cases of dermatofibrosarcoma protuberans using formalin-fixed, paraffin-embedded tissues.
    Saeki H; Tsunemi Y; Ohtsuki M; Kikuchi K; Tamaki K
    Acta Derm Venereol; 2005; 85(3):221-4. PubMed ID: 16040406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].
    Bianchini L; Maire G; Pedeutour F;
    Bull Cancer; 2007 Feb; 94(2):179-89. PubMed ID: 17337387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans.
    Wang J; Morimitsu Y; Okamoto S; Hisaoka M; Ishida T; Sheng W; Hashimoto H
    J Mol Diagn; 2000 Feb; 2(1):47-52. PubMed ID: 11272901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin.
    Wang WL; Patel KU; Coleman NM; Smith-Zagone MJ; Ivan D; Reed JA; López-Terrada D; Lazar AJ; Prieto VG
    Am J Dermatopathol; 2010 Apr; 32(2):149-53. PubMed ID: 19940748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas.
    O'Brien KP; Seroussi E; Dal Cin P; Sciot R; Mandahl N; Fletcher JA; Turc-Carel C; Dumanski JP
    Genes Chromosomes Cancer; 1998 Oct; 23(2):187-93. PubMed ID: 9739023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and clinicopathological analysis of dermatofibrosarcoma protuberans.
    Walluks K; Chen Y; Woelfel C; Yang L; Cui T; Seliger C; Geier C; Knösel T; Hauke S; Petersen I
    Pathol Res Pract; 2013 Jan; 209(1):30-5. PubMed ID: 23207290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.
    McArthur GA; Demetri GD; van Oosterom A; Heinrich MC; Debiec-Rychter M; Corless CL; Nikolova Z; Dimitrijevic S; Fletcher JA
    J Clin Oncol; 2005 Feb; 23(4):866-73. PubMed ID: 15681532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans.
    Sheng WQ; Hashimoto H; Okamoto S; Ishida T; Meis-Kindblom JM; Kindblom LG; Hisaoka M
    J Pathol; 2001 May; 194(1):88-94. PubMed ID: 11329146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatofibrosarcoma protuberans: a study of clinical, pathologic, genetic, and therapeutic features in Korean patients.
    Zheng Z; Piao J; Lee JH; Kim SE; Kim SC; Chung KY; Roh MR
    Yonsei Med J; 2015 Mar; 56(2):440-6. PubMed ID: 25683993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment.
    Sirvent N; Maire G; Pedeutour F
    Genes Chromosomes Cancer; 2003 May; 37(1):1-19. PubMed ID: 12661001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications.
    Ha SY; Lee SE; Kwon MJ; Kim YJ; Lee EH; Seo J; Jang KT; Lee J; Choi YL
    Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans.
    Kutzner H; Mentzel T; Palmedo G; Hantschke M; Rütten A; Paredes BE; Schärer L; Guillen CS; Requena L
    Am J Surg Pathol; 2010 Feb; 34(2):190-201. PubMed ID: 20061935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
    Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
    J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New molecular approaches in dermatofibrosarcoma protuberans].
    Kaya G
    Rev Med Suisse; 2009 Jul; 5(211):1519-24. PubMed ID: 19694363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans.
    Macarenco RS; Zamolyi R; Franco MF; Nascimento AG; Abott JJ; Wang X; Erickson-Johnson MR; Oliveira AM
    Genes Chromosomes Cancer; 2008 Mar; 47(3):260-5. PubMed ID: 18069662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDGFB quantification is a useful tool in the diagnosis of dermatofibrosarcoma protuberans: a study of 10 cases.
    Muchemwa FC; Wakasugi S; Honda Y; Ihn H
    Clin Exp Dermatol; 2010 Apr; 35(3):295-9. PubMed ID: 19663837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.